5 recruiting, 2 completed, 2 unknown, 1 not yet recruiting. 3 Phase 1, 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Not applicable | 2 | Recruiting 2 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Pediatric Solid Tumors: new trials by email Literature Review of Pediatric Solid Tumors trials Research Report on Pediatric Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tumor-Lymph Node Mapping ICG (Indocyanine Green) - Pediatric Solid Tumors, Rhabdomyosarcoma | Not yet recruiting | University of Rochester | 10 | 2026-12-13 | 2026-08-26 | |
| Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma Proton Therapy (Adaptive) - Pediatric Solid Tumors, Rhabdomyosarcoma | Not applicable | Recruiting | St. Jude Children's Research Hospital | 100 | 2026-08-20 | 2026-08-21 |
| Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers Psycho-education and Psychological intervention_After cancer treatment, Psycho-education and Psychological intervention_In cancer treatment - Pediatric Solid Tumors | Not applicable | Recruiting | National Cancer Center, Korea | 120 | 2023-12-27 | 2025-05-14 |
| Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy Pediatric Solid Tumors | Recruiting | Fondazione IRCCS Policlinico San Matteo di Pavia | 44 | 2023-01-19 | 2025-11-20 | |
| Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors Biological - Refractory/Relapse Neuroblastoma, Pediatric Solid Tumors | Phase 1 | Recruiting | Kyushu University | 61 | 2022-10-26 | 2026-08-07 |
| Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers Pediatric Solid Tumors | Unknown | University Hospital, Strasbourg, France | 230 | 2022-06-20 | 2023-12-15 | |
| Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors Pediatric Solid Tumors | Unknown | National Council of Scientific and Technical Research, Argentina | 100 | 2021-02-01 | 2021-02-26 | |
| Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan Sorafenib, Irinotecan - Pediatric Solid Tumors | Phase 2 | Withdrawn | Washington University School of Medicine | 2016-06-24 | 2019-09-09 | |
| Molecular Analysis Of Solid Tumors Pediatric Solid Tumors | Recruiting | St. Jude Children's Research Hospital | 1000 | 2010-02-10 | 2025-11-12 | |
| Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors perifosine + temsirolimus - Pediatric Solid Tumors | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 23 | 2010-01-01 | 2017-03-10 |
| A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) Carboplatin, Irinotecan - Pediatric Solid Tumors | Phase 1 / Phase 2 | Completed | Bristol-Myers Squibb | 20 | 2004-01-01 | 2010-02-05 |
Rhabdomyosarcoma (3) · Sarcoma (3) · Osteosarcoma (2) · Sarcoma, Ewing (2) · Bone Neoplasms (1) · Hodgkin Disease (1) · Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Neuroblastoma (1) · Recurrence (1) · Retinoblastoma (1)
Myosarcoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Muscle Tissue (3) · Neoplasms (2) · Neoplasms by Site (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Connective Tissue (2) · Bone Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Eye Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1)
Irinotecan (2) · Biological Products (1) · Carboplatin (1) · Proton Therapy (1) · Sorafenib (1) · perifosine (1) · temsirolimus (1)
St. Jude Children's Research Hospital (2) · Bristol-Myers Squibb (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Kyushu University (1) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Center, Korea (1) · National Council of Scientific and Technical Research, Argentina (1) · University Hospital, Strasbourg, France (1) · University of Rochester (1) · Washington University School of Medicine (1)
United States (4) · Argentina (1) · France (1) · Italy (1) · Japan (1) · South Korea (1)
Alok Kothari, M.D. (1) · Ira Dunkel, MD (1) · Ozgur Ates, PhD (1) · Sara M. Federico, MD (1)